Net Cash Provided by (Used in) Financing Activities of VitaNova Life Sciences Corp from 25 Jan 2017 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
VitaNova Life Sciences Corp quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 25 Jan 2017 to 31 Jul 2025.
  • VitaNova Life Sciences Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Jul 2025 was $0, a 100% decline year-over-year.
  • VitaNova Life Sciences Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $3,000, a 100% decline from 2023.
  • VitaNova Life Sciences Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $960,188, a 23905% increase from 2022.
  • VitaNova Life Sciences Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4,000, a 79% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

VitaNova Life Sciences Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 -$52,600 -100% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2026 Q1
Q2 2024 $52,600 +$35,181 +202% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2026 Q1
Q2 2023 $17,419 +$17,419 01 May 2023 31 Jul 2023 10-Q 10 Sep 2024 2025 Q1
Q2 2022 $0 -$6,942 -100% 01 May 2022 31 Jul 2022 10-Q 14 Sep 2023 2024 Q1
Q2 2021 $6,942 +$6,942 01 May 2021 31 Jul 2021 10-Q 01 Sep 2022 2022 Q1
Q2 2020 $0 -$19,884 -100% 01 May 2020 31 Jul 2020 10-Q 20 Aug 2021 2022 Q1
Q2 2019 $19,884 +$12,884 +184% 01 May 2019 31 Jul 2019 10-Q 18 Sep 2020 2021 Q1
Q2 2018 $7,000 +$7,000 01 May 2018 31 Jul 2018 10-Q 12 Sep 2019 2020 Q1
Q2 2017 $0 01 May 2017 31 Jul 2017 10-Q 17 Aug 2018 2019 Q1

VitaNova Life Sciences Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,000 -$963,188 -100% 01 May 2024 30 Apr 2025 10-K 24 Jul 2025 2025 FY
2023 $960,188 +$956,188 +23905% 01 May 2023 30 Apr 2024 10-K 24 Jul 2025 2025 FY
2022 $4,000 -$15,042 -79% 01 May 2022 30 Apr 2023 10-K 29 Jul 2024 2024 FY
2021 $19,042 -$23,244 -55% 01 May 2021 30 Apr 2022 10-K 15 May 2023 2023 FY
2020 $42,286 -$11,293 -21% 01 May 2020 30 Apr 2021 10-K 16 May 2022 2022 FY
2019 $53,579 +$8,887 +20% 01 May 2019 30 Apr 2020 10-K 01 Jul 2021 2021 FY
2018 $44,692 -$2,733 -5.8% 01 May 2018 30 Apr 2019 10-K 05 Aug 2020 2020 FY
2017 $47,425 +$38,325 +421% 01 May 2017 30 Apr 2018 10-K 30 Jul 2019 2019 FY
2016 $9,100 23 Jan 2016 25 Jan 2017 10-K 17 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.